Brookfield Asset Management and Warburg Pincus anchored $43.3 billion in combined private equity and venture capital deal value in July, the second consecutive monthly increase after six months of sub-$40 billion prints. The volume represents a 19% gain over June's $36.4 billion and the highest monthly total since March.
Brookfield closed its acquisition of a portfolio of U.S. renewable energy assets from a European pension consortium for approximately $4.7 billion, while Warburg Pincus led a $3.2 billion take-private of a mid-cap healthcare IT platform. The two transactions accounted for roughly 18% of global deal value in a month where no mega-deal above $10 billion printed. Deal count rose to 847 transactions, up from 791 in June, with median check size holding at $28 million—unchanged since April.
The pattern matters because it breaks the first half's stall. January through May saw average monthly volume of $37.1 billion, well below the $52 billion monthly average that characterized 2021–2022. July's uptick follows a June rebound driven largely by Asian infrastructure and European industrials repricing after three quarters of valuation compression. The Brookfield and Warburg deals both closed at multiples below their respective sectors' 2022 peaks—renewable energy at 9.2x EBITDA versus a prior 11.8x, healthcare IT at 13.1x versus 15.9x—but above the trough multiples seen in Q1 2024. Allocators now face a narrowing window: asset prices have lifted off distressed levels but remain 12–17% below cycle highs, while debt markets have reopened with covenant-lite issuance returning to 68% of new leveraged loans, up from 41% in January.
The composition of July's volume also signals a shift. North American deals contributed $24.8 billion, or 57% of total value, compared to a 48% share in the prior six-month period. European volume fell to $11.2 billion from an average $14.6 billion monthly in Q2, as regulatory delays in Germany and France slowed closings. Asia-Pacific held at $7.3 billion, concentrated in three sectors: logistics infrastructure, semiconductor tooling, and consumer healthcare. Warburg's healthcare IT transaction was the largest U.S. software take-private since October 2023, and Brookfield's renewable deal was its fourth energy infrastructure acquisition above $3 billion in the past nine months, underscoring the firm's systematic sector build.
Allocators should monitor September's volume print closely. August data will likely show a seasonal dip—historic patterns put August 8–12% below July—but September typically rebounds as fund managers push to deploy capital ahead of Q4. Brookfield has $14 billion in uninvested flagship fund commitments and has publicly stated intent to close two additional renewables transactions before year-end. Warburg is marketing a $7.5 billion continuation vehicle tied to three portfolio companies, expected to price in late October. If September volume holds above $42 billion, it would mark three consecutive months of expansion, a pattern last seen in Q3 2022 before rates spiked. The next inflection point is the Federal Reserve's September decision: if the Fed holds or cuts 25 basis points, deal activity likely accelerates; a hawkish hold would stall momentum into Q4.
Two Brookfield renewable projects acquired in July are slated to begin commercial operations in Q1 2025, with offtake agreements already locked at rates 14% above current spot pricing.